$7 Million Pledged To SENS Longevity Research
I'm pleased to note that pledged funds for Strategies for Engineered Negligible Senescence (SENS) research, aimed at repairing and reversing the damage of aging, have passed the $7 million mark. Congratulations are due to all the Methuselah Foundation volunteers and generous donors who have made our ongoing SENS research programs a reality. Thank you all!
You can find out more about the SENS research funded and organized by the Methuselah Foundation at our website, and in the most recent progress report issued by the Foundation:
The Foundation currently sponsors research in two of the seven strands of the SENS program: preventing the harm caused by mitochondrial mutations (MitoSENS) and degrading damaging, long-lived cellular debris (LysoSENS)....
A selection of [further] projects within the SENS plan are ready to be launched as Foundation-sponsored research programs. [As] for MitoSENS and LysoSENS, these projects will start small (likely with only a single researcher), with the aim of delivering high leverage in terms of the credibility of the approach.
We look forward to continued expansion and progress in the year ahead.